Mendelian randomization reveals immune cell composition as a key determinant of cervical cancer prognosis
Our study utilizing the Mendelian Randomization approach provides novel insights into the causal relationships between the immune microenvironment of cervical cancer and its prognosis. The identified immune cell markers (monocyte counts, T cell ratios) have the potential to serve as prognostic biomarkers and to inform the design of targeted immunotherapeutic approaches in cervical cancer.
Authors
- Yangyang Chen
- Dongdong Zhong
Institutions
- Wenzhou City People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1007/s12672-025-02455-w
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94